Search Browse Earnings

Camp4 Therapeutics Corp — SlamSEC

Camp4 Therapeutics Corp

Nasdaq:CAMP

Pharmaceutical Preparations·CAMBRIDGE, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$652,000

+86.3% YoY

FY 2025

Adj. EBITDA

-$51.4M

-7882.2% margin

FY 2025

Net Income

-$51.8M

-7943.4% margin

FY 2025

EPS (Diluted)

-$11.04

FY 2025

Stock Price

$6.79

+47.8%

2026-03-09

52W Range

$1.30 – $7.30

P/E Ratio

-0.6x

Market Cap

$352.6M

Cash

$64.0M

FY 2025

Total Debt

—

Net Cash

$64.0M

FY 2025

Enterprise Value

$288.5M

Debt / EBITDA

1.2x

FY 2025

EV / EBITDA

-5.6x

Employees

—

CEO

Mandel-Brehm Josh

CFO

Gold Kelly